Unknown

Dataset Information

0

Insulin and Metformin Control Cell Proliferation by Regulating TDG-Mediated DNA Demethylation in Liver and Breast Cancer Cells.


ABSTRACT: Type 2 diabetes mellitus (T2DM) is a frequent comorbidity of cancer. Hyperinsulinemia secondary to T2DM promotes cancer progression, whereas antidiabetic agents, such as metformin, have anticancer effects. However, the detailed mechanism for insulin and metformin-regulated cancer cell proliferation remains unclear. This study identified a mechanism by which insulin upregulated the expression of c-Myc, sterol regulatory element-binding protein 1 (SREBP1), and acetyl-coenzyme A (CoA) carboxylase 1 (ACC1), which are important regulators of lipogenesis and cell proliferation. Thymine DNA glycosylase (TDG), a DNA demethylase, was transactivated by c-Myc upon insulin treatment, thereby decreasing 5-carboxylcytosine (5caC) abundance in the SREBP1 promoter. On the other hand, metformin-activated AMP-activated protein kinase (AMPK) increased DNA methyltransferase 3A (DNMT3A) activity to increase 5-methylcytosine (5mC) abundance in the TDG promoter. This resulted in decreased TDG expression and enhanced 5caC abundance in the SREBP1 promoter. These findings demonstrate that c-Myc activates, whereas AMPK inhibits, TDG-mediated DNA demethylation of the SREBP1 promoter in insulin-promoted and metformin-suppressed cancer progression, respectively. This study indicates that TDG is an epigenetic-based therapeutic target for cancers associated with T2DM.

SUBMITTER: Yan JB 

PROVIDER: S-EPMC7378318 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Insulin and Metformin Control Cell Proliferation by Regulating TDG-Mediated DNA Demethylation in Liver and Breast Cancer Cells.

Yan Jia-Bao JB   Lai Chien-Cheng CC   Jhu Jin-Wei JW   Gongol Brendan B   Marin Traci L TL   Lin Shih-Chieh SC   Chiu Hsiang-Yi HY   Yen Chia-Jui CJ   Wang Liang-Yi LY   Peng I-Chen IC  

Molecular therapy oncolytics 20200624


Type 2 diabetes mellitus (T2DM) is a frequent comorbidity of cancer. Hyperinsulinemia secondary to T2DM promotes cancer progression, whereas antidiabetic agents, such as metformin, have anticancer effects. However, the detailed mechanism for insulin and metformin-regulated cancer cell proliferation remains unclear. This study identified a mechanism by which insulin upregulated the expression of c-Myc, sterol regulatory element-binding protein 1 (SREBP1), and acetyl-coenzyme A (CoA) carboxylase 1  ...[more]

Similar Datasets

| S-EPMC11294444 | biostudies-literature
| S-EPMC4417182 | biostudies-literature
| S-EPMC4046508 | biostudies-literature
| S-EPMC5054525 | biostudies-literature
| S-EPMC8005466 | biostudies-literature
| S-EPMC4894546 | biostudies-literature
| S-EPMC4629659 | biostudies-literature
2015-05-07 | GSE62496 | GEO
| S-EPMC3368818 | biostudies-literature
2015-05-07 | E-GEOD-62496 | biostudies-arrayexpress